%%subject%%

ACLA Meeting Spotlights Value of Clinical Diagnostics in Face of Reimbursement, Regulatory Challenges

Email not displaying correctly?
View it in your browser.



	March 8, 2016

HEALTH CARE REFORM
ACLA Meeting Spotlights Value of Clinical Diagnostics in Face of Reimbursement, Regulatory Challenges
By Stephanie Murg, Managing Director, G2 Intelligence
Despite the looming challenges of a proposed overhaul of the Medicare payment system for clinical laboratory services and…
Read More

ENFORCEMENT
Kickback Case Settles for Record-breaking $646 Million
By Kelly A. Briganti, Editorial Director, G2 Intelligence
It has been billed as the largest total amount in U.S. history paid for alleged violations of the Anti-kickback Statute by…
Read More

PRICING
Veritas Launches Below-$1,000 Whole Genome Test
By Ron Shinkman, Editor, Laboratory Industry Report
Veritas Genetics is launching a whole genome test under the four-figure price point…
Read More

PRECISION MEDICINE
More Than 1/4 of FDA's 2015 Drug Approvals for Targeted Therapies
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
Read More

Follow on Twitter | Forward to a Friend

For questions concerning delivery of this email, please contact customer service at: (888) 729-2315 | customerservice@plainlanguagemedia.com

Unsubscribe